Tanja Groten, Thomas Lehmann, Mariann Städtler, Matej Komar, Jennifer Lucia Winkler, Mateja Condic, Brigitte Strizek, Sven Seeger, Yvonne Jäger, Ulrich Pecks, Christel Eckmann-Scholz, Karl Oliver Kagan, Markus Hoopmann, Constantin S von Kaisenberg, Bettina Hertel, Anne Tauscher, Susanne Schrey-Petersen, Ulrike Friebe-Hoffmann, Krisztian Lato, Christoph Hübener, Maria Delius, Stefan Verlohren, Dorota Sroka, Dietmar Schlembach, Laura de Vries, Katrina Kraft, Gregor Seliger, Ekkehard Schleußner
BACKGROUND: This is a follow up study to the PETN randomized controlled multicenter trial that reports neonatal outcome data of newborns admitted to neonatal intensive care units (NICU) and outcome data of the offspring at 12 months of age. OBJECTIVE AND STUDY DESIGN: The PETN-trial was a randomized, double blind, placebo-controlled study designed to assess the efficacy and safety of the NO-donor pentaerytrithyltetranitrate (PETN) in the prevention of fetal growth restriction (FGR) and perinatal death in pregnancies complicated by abnormal placental perfusion...
March 7, 2024: American journal of obstetrics & gynecology MFM